Cargando…
Human Disease-Drug Network Based on Genomic Expression Profiles
BACKGROUND: Drug repositioning offers the possibility of faster development times and reduced risks in drug discovery. With the rapid development of high-throughput technologies and ever-increasing accumulation of whole genome-level datasets, an increasing number of diseases and drugs can be compreh...
Autores principales: | Hu, Guanghui, Agarwal, Pankaj |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715883/ https://www.ncbi.nlm.nih.gov/pubmed/19657382 http://dx.doi.org/10.1371/journal.pone.0006536 |
Ejemplares similares
-
A Pathway-Based View of Human Diseases and Disease Relationships
por: Li, Yong, et al.
Publicado: (2009) -
Systematic Drug Repositioning Based on Clinical Side-Effects
por: Yang, Lun, et al.
Publicado: (2011) -
Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues
por: Kumar, Vinod, et al.
Publicado: (2016) -
Connecting genetics and gene expression data for target prioritisation and drug repositioning
por: Ferrero, Enrico, et al.
Publicado: (2018) -
The genomic profiling and MAMLD1 expression in human and canines with Cushing’s disease
por: Wang, Andrew, et al.
Publicado: (2021)